CClinicalTrials.gg
Active, not recruitingNCT03507049SIFSOUpdated Jul 11, 2022

Sacroiliac Joint Fusion Versus Sham Operation for Treatment of Sacroiliac Joint Pain

An interventional study of iFuse and sham group in Sacroiliac Joint Somatic Dysfunction, sponsored by Oslo University Hospital. Active, not recruiting at 2 sites in 2 countries. Open to participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-07-11.

Sponsored by Oslo University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
63
Allocation
Randomized
Ages
21 Years to 70 Years
Sex
All
01

Study summary

Sacroiliac joint fusion versus sham operasjon for treatment of sacroiliac pain. A prospective double blinded randomized controlled multicentre study.

Read the detailed description

Sacroiliac(SI) joint pain can lead to long-lasting severe pain and reduce physical function. It is shown to be the source of pain in 13-30% of patients with low back pain. Former surgical techniques had a high level of complications and low success rates. Newer mini-invasive surgical approaches have shown promising results in scientific studies. It is difficult to find an adequate control group for surgery as most patients already have tried conservative and alternative treatments without effect. A sham-designed study is the best alternative. This study is designed as a prospective randomized double blinded controlled mulitcenter trial. The investigators want to examine whether there is a difference in SI joint pain in patients operated with miniinvasive arthrodesis of the SI joint compared to a sham operated control group. Patients with SI joint pain are included. They will be randomized to either surgery with arthrodesis or sham surgery. Neither patient nor health personell who work with the patient after the surgery will know what has been done. The primary end point for the study is group difference in sacroiliac joint pain on the operated side after 6 months.

02

Conditions studied

  • Sacroiliac Joint Somatic Dysfunction
03

In context

Arthralgia

273 studies on the registry are indexed under Arthralgia; 41 are open to participants now.

This study's enrollment of 63 is close to the median of 63 across 219 interventional studies indexed under Arthralgia.

Browse Arthralgia studies →

Lead sponsor

Oslo University Hospital is the lead sponsor of 810 studies on the registry; 148 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age 21-70 at time of screening
  2. Patient with suspected SIJ pain for >6 months or >18 months for pregnancy induced pelvic girdle pain.
  3. Diagnosis of the SI joint as the primary pain generator based on ALL of the following:

A. Patient has pain at or close to the posterior superior iliac spine (PSIS) with possible radiation into buttocks, posterior thigh or groin and can point with a single finger to the location of pain (Fortin Finger Test)

B. Patient has at least 3 of 6 physical examination maneuvers specific for SI joint pain:

  1. Compression
  2. Posterior Pelvic Pain Provocation test - P4 (Thigh Thrust)
  3. Palpation of the long dorsal ligament
  4. Patrick's test (Faber)
  5. Leg Raise (ASLR )
  6. Geanslens test

C. Patient has improvement in lower back pain NRS of at least 50% of the pre injection NRS score after fluoroscopic controlled injection of local anesthetic into affected SI joint (including previous documented test \<6 months ago)

  1. Baseline Oswestry Disability Index (ODI) score of at least 30%
  1. Baseline lower back pain score of at least 5 on 0-10 point NRS
  1. Patient should have tried adequate forms of conservative treatment with little or no response.
  1. Patient has signed study-specific informed consent
  1. Patient has the necessary mental capacity to participate and is physically able to comply with study protocol requirements.
  1. Patients with unilateral or bilateral pain can be included in the study if they clearly can differentiate between the two sides. It is the most painful side that will be included and randomized to SIJ fusion or sham surgery in the study.

Exclusion criteria

Exclusion Criteria:

  1. Severe low back pain due to other causes, such as lumbar disc degeneration, lumbar disc herniation, lumbar spondylolisthesis, lumbar spinal stenosis, lumbar facet degeneration, and lumbar vertebral body fracture.
  2. Sacroiliac pathology caused by auto-immune disease (e.g. ankylosing spondylitis) and/or neoplasia (e.g. benign or malignant tumor) and/or crystal arthropathy
  3. History of recent (\<1 year) fracture of the pelvis with documented malunion, non-union of sacrum or ilium or any type of internal fixation of the pelvic ring.
  4. Spine surgery during the past 12 months.
  5. Previously diagnosed or suspected osteoporosis (defined as prior T-score \<-2.5 or history of osteoporotic fracture)
  6. Documented osteomalacia or other metabolic bone disease
  7. Any condition or anatomy that makes treatment with the iFuse Implant System infeasible
  8. Patients with prior successful fusion to the contra lateral side are exluded from the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
63 participants (actual)

Study arms

  • Active comparator
    Intervention group

    The intervention Group receives operation with SI-joint arthrodesis with the iFuse implant. The patient undergoes full anesthesia. The procedure starts with an approximately 5cm long skin incision over the posterolateral aspect of the pelvis. A guide-pin is inserted over the sacroiliac joint at the desired entry-point, verified by fluoroscopy. The surgeons drills and boraches over the pin and the ifuse implant is inserted. This is repeated for a total of three implants. The wound is closed with non-resorbable suture. An injection of the SIJ with local anesthetic is performed under guidance of fluoroscopy at the time of the procedure.

    Procedure: iFuse

  • Sham comparator
    Sham group

    The sham operation will consist of the surgeon making the same skin incision as for an iFuse procedure, although nothing more, and then closing the wound. The patients undergoing a sham operation will be under general anesthesia for a random time of 20-40minutes in order to keep the two procedures as similar as possible. An injection of the SIJ with local anesthetic is performed under guidance of fluoroscopy at the time of the procedure.

    Procedure: sham group

  • Other
    Functional MRI study

    The Swedish patients will also undergo quantitative sensory testing at inclusion and at 6 month follow-up. At the same time they will undergo a cerebral MRI and a Functional MRI looking at activation of the CNS from pain in the sacroiliac joints induced by one leg lift. The purpose of this study is to look at contributing factors in treatment response. One hopes to map which CNS mechanisms are involved in causing the chronic pain these patients experience as well as how they respond to treatment.

    Radiation: fMRI study

Interventions

  • ProcedureiFuse

    ifuse will be implanted as described in section on the active comparator arm of the study.

    Also known as: SI Bone iFuse

  • Proceduresham group

    sham surgery will be performed as desrcribed in section on sham comparator.

    Also known as: Sham surgery

  • RadiationfMRI study

    Quantitative sensory testing, cerebral MRI and functional MRI will be done to examine pain mechanism and activation in the central nervous system.

06

What researchers measure

Primary outcomes

  1. Primary outcome measure - Numeric Rating Scale operated side

    the primary endpoint is group difference in Numeric Rating Scale(NRS) pain-score on the operated side at six months postoperatively. Numeric rating scale is a pain-score scale from 0-10, where 0 is no pain and 10 is worst possible pain.

    Time frame: 6 months

Secondary outcomes

  1. Baseline NRS

    Change from baseline Numeric Rating Scale (NRS) pain-score on the operated side at 3,6,12 and 24 months

    Time frame: baseline, 3, 6, 12 and 24 months

  2. Global NRS

    Change from baseline global NRS at 3,6,12 and 24 months

    Time frame: baseline,3 ,6 ,12 ,24 months

  3. NRS on non-operated side

    Change from baseline in non-operated side NRS at 3,6,12 and 24 months

    Time frame: baseline, 3, 6, 12, 24 months

  4. NRS leg pain

    Change from baseline leg pain NRS at 3,6,12,24 months

    Time frame: baseline, 3,6,12,24 months

  5. Oswestry disability index (ODI)

    Change in disability due to pelvic pain measured by Oswestry Disability Index(ODI) at 3,6,12,24 months

    Time frame: baseline, 3, 6,12, 24 months

  6. Pelvic girdle questionnaire

    Change in disability due to pelvic pain measured by Pelvic Girdle Questionnaire(PGQ) at 3,6,12,24 months

    Time frame: baseline, 3, 6, 12, 24 months

  7. Quality of life (EQ-5D)

    Change in quality of life measured by EQ-5D at 3,6,12,24 months

    Time frame: baseline, 3, 6, 12, 24 months

  8. Device breakage, loosening or migration on CT of the sacroiliac joint

    Device breakage loosening or migration at 12 months judged by clinical symptoms and CT of the sacroiliac joint.

    Time frame: 12 months

Other outcomes

  1. Adverse events

    registration of any adverse events after procedure completed

    Time frame: 3,6,12,24 months

  2. Change in Compression test of the sacroiliac joint

    Change in compression test of the sacroiliac joint which is an objective clinical test. Outcome is negative or positive test dependent on whether pain is provoked or not in the sacroiliac joint.

    Time frame: baseline, 3, 6,12, 24 months

  3. Change in Posterior Pelvic Pain Provocation (P4) test of the sacroiliac joint

    Change in Posterior Pelvic pain Provocation (P4) test of the sacroiliac joint which is an objective clinical test. Outcome is negative or positive test dependent on whether pain is provoked or not in the sacroiliac joint.

    Time frame: baseline, 3, 6,12, 24 months

  4. Change in Palpation of long dorsal ligament as test of the sacroiliac joint

    Change in Palpation of long dorsal ligament as test of the sacroiliac joint which is an objective clinical test. Outcome is negative or positive test dependent on whether pain is provoked or not along the ligament.

    Time frame: baseline, 3, 6,12, 24 months

  5. Change in Patricks (FABER) test of the sacroiliac joint

    Change in Patricks (FABER) test of the sacroiliac joint which is an objective clinical test. Outcome is negative or positive test dependent on whether pain is provoked or not in the sacroiliac joint. .

    Time frame: baseline, 3, 6,12, 24 months

  6. Change in active straight leg raise test (ASLR) of the sacroiliac joint

    Change in active straight leg raise test(ASLR) of the sacroiliac joint which is an objective clinical test. Results are recorded on a grad 0 to 5, where not difficult at all = 0; minimally difficult = 1; somewhat difficult = 2; fairly difficult = 3; very difficult = 4; unable to do = 5.

    Time frame: baseline, 3, 6,12, 24 months

  7. Change in Gaenslens test

    Change in Gaenslens test which is an objective clinical tests for the sacroiliac joint. Outcome is recorded as positive or negative test dependent on whether pain is provoked or not in the sacroiliac joint.

    Time frame: baseline, 3, 6,12, 24 months

  8. 6 minute walk test to record ambulatory status

    Patients will be tested with 6minute walk test to test ambulatory status. The test is performed by marking a distance equal to 50meters. The patient is instructed to walk back and forth between the marks as quickly and as many times as they manage in 6 minutes. The total distance walked is recorded.

    Time frame: baseline, 3, 6,12, 24 months.

  9. Timed up and og test to record ambulatory status

    Patients will be tested with Timed up and go, to test ambulatory status.Timed up and go test the time it takes the patient to get up from a Chair, walk 3 meters and back and be seated again.

    Time frame: baseline, 3, 6,12, 24 months.

  10. Work status

    Patients will be asked to fill out standardized questionnaire on work status

    Time frame: baseline, 3, 6,12, 24 months.

07

Study locations

2 sites
  • Rikshospitalet, Oslo University Hospital
    Oslo, 0424, Norway
  • Karolinska University Hospital
    Stockholm, Sweden
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Jun 30, 2022

Documents are hosted by the registry — open the source record to download them.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03507049
Lead sponsor
Oslo University Hospital
Collaborators
Karolinska University Hospital
Responsible party
Thomas Johan Kibsgård (Senior consultant, associated professor, Oslo University Hospital) — Principal investigator
First posted
Apr 24, 2018
Start date
Jun 8, 2018
Primary completion
May 25, 2022
Completion
May 25, 2030 (estimated)
Last update
Jul 11, 2022

Study contacts

Thomas Johan Dr Kibsgård, PhD, MD
principal investigator · Oslo University Hospital
Paul Dr Gerdhem, PhD, MD
study chair · Karolinska University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion